Page last updated: 2024-08-17

medroxyprogesterone acetate and Adenomyoma

medroxyprogesterone acetate has been researched along with Adenomyoma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Bertozzi, S; Biasioli, A; Cagnacci, A; Londero, AP; Mangino, FP; Mariuzzi, L; Orsaria, M; Scrimin, F	1
Kanao, H; Kato, K; Matoda, M; Nomura, H; Okamoto, S; Omatsu, K; Sugiyama, Y; Takeshima, N; Tanigawa, T; Utsugi, K	1
Kanao, H; Kondo, E; Matoda, M; Nomura, H; Sugiyama, Y; Takeshima, N; Tanigawa, T	1

Reviews

1 review(s) available for medroxyprogesterone acetate and Adenomyoma

Article	Year
Atypical polypoid adenomyoma follow-up and management: Systematic review of case reports and series and meta-analysis. Medicine, 2020, Jun-26, Volume: 99, Issue:26 Topics: Adenomyoma; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Conservative Treatment; Curettage; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysteroscopy; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pregnancy; Pregnancy Rate; Uterine Neoplasms	2020

Article

Year

Atypical polypoid adenomyoma follow-up and management: Systematic review of case reports and series and meta-analysis.

Medicine, 2020, Jun-26, Volume: 99, Issue:26

Topics: Adenomyoma; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Conservative Treatment; Curettage; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysteroscopy; Medroxyprogesterone Acetate; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pregnancy; Pregnancy Rate; Uterine Neoplasms

2020

Other Studies

2 other study(ies) available for medroxyprogesterone acetate and Adenomyoma

Article	Year
Maintenance hormonal therapy after treatment with medroxyprogesterone acetate for patients with atypical polypoid adenomyoma. Japanese journal of clinical oncology, 2018, Mar-01, Volume: 48, Issue:3 Topics: Adenomyoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Kaplan-Meier Estimate; Maintenance Chemotherapy; Medroxyprogesterone Acetate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Retrospective Studies; Risk Factors; Treatment Outcome	2018
Long-term outcomes of fertility-sparing treatment of atypical polypoid adenomyoma with medroxyprogesterone acetate. Archives of gynecology and obstetrics, 2016, Volume: 293, Issue:1 Topics: Adenomyoma; Adult; Aged; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Fertility Preservation; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Rate; Prognosis; Remission Induction; Retrospective Studies; Time Factors; Uterine Neoplasms	2016

Article

Year

Maintenance hormonal therapy after treatment with medroxyprogesterone acetate for patients with atypical polypoid adenomyoma.

Japanese journal of clinical oncology, 2018, Mar-01, Volume: 48, Issue:3

Topics: Adenomyoma; Adult; Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Fertility Preservation; Humans; Kaplan-Meier Estimate; Maintenance Chemotherapy; Medroxyprogesterone Acetate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Retrospective Studies; Risk Factors; Treatment Outcome

2018

Long-term outcomes of fertility-sparing treatment of atypical polypoid adenomyoma with medroxyprogesterone acetate.

Archives of gynecology and obstetrics, 2016, Volume: 293, Issue:1

Topics: Adenomyoma; Adult; Aged; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fertility; Fertility Preservation; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Pregnancy; Pregnancy Rate; Prognosis; Remission Induction; Retrospective Studies; Time Factors; Uterine Neoplasms

2016